Vyloo

Lacarnit 330 Tablet

ContainsLevo-carnitine (330mg)
Prescription Required
Store below 30C
MRP₹207.1920% OFF
₹165.75

Inclusive of all taxes

Packaging:10.0 tablets in 1 strip
Lacarnit 330 Tablet – Levo-carnitine (330mg) 330 mg by La Renon Healthcare Pvt Ltd
Click to enlarge

Fast Delivery

Express dispatch for Lacarnit 330 Tablet across India, with fast delivery in Delhi NCR, Noida, and Ghaziabad.

Licensed Pharmacy
Rx Verification
Fast Dispatch

Quick Facts

Chemical ClassAmino acids
Habit FormingNo
Therapeutic ClassVITAMINS MINERALS NUTRIENTS
Action ClassAmino acids

About Lacarnit 330 Tablet

Lacarnit 330 Tablet belongs to a class of medications called amino acids. It is used in the treatment of carnitine deficiency. It helps the body produce energy and improve the efficiency of body function.Lacarnit 330 Tablet should be taken with food and it should be chewed thoroughly before swallowing. Take it in the dose and duration as advised by your doctor. Do not start or stop taking this medicine without a doctor's prescription.Lacarnit 330 Tablet is usually a safe medicine, however, it may cause nausea and vomiting. Your doctor may suggest you to monitor your blood glucose levels regularly while you are taking the medicine.Before starting the medicine, inform your doctor if you have any other medical conditions or are taking any other medications. Patients with severe kidney disease should not take this medicine unless prescribed by the doctor.

How It Works

Lacarnit 330 Tablet belongs to a class of medications called amino acids. It is used in the treatment of carnitine deficiency. It helps the body produce energy and improve the efficiency of body function.Lacarnit 330 Tablet should be taken with food and it should be chewed thoroughly before swallowing. Take it in the dose and duration as advised by your doctor. Do not start or stop taking this medicine without a doctor's prescription.Lacarnit 330 Tablet is usually a safe medicine, however, it may cause nausea and vomiting. Your doctor may suggest you to monitor your blood glucose levels regularly while you are taking the medicine.Before starting the medicine, inform your doctor if you have any other medical conditions or are taking any other medications. Patients with severe kidney disease should not take this medicine unless prescribed by the doctor.

How to Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lacarnit 330 Tablet is to be taken with food.

What if you miss a dose?

If you miss a dose of Lacarnit 330 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Storage

Store below 30C

Prescription required. Upload a valid prescription at checkout or via prescription upload.

Composition of Lacarnit 330 Tablet

Key Benefits of Lacarnit 330 Tablet

  • In Carnitine deficiency Carnitine deficiency can lead to many problems such as muscle weakness, fatigue, problems with heart (such as heart enlargement), liver or brain (encephalopathy), confusion etc. Lacarnit 330 Tablet contains amino acids that are very important for the normal growth and development of the internal organs, muscles and nerves. It helps to maintain normal functioning of the internal organs and maintains nerve conduction too. It has a major role in the generation of energy in our body, regulation of mood, healing and repair of damaged tissues and keeping our skin, nails and hair healthy. Keep taking it as prescribed by the doctor to get the maximum benefit.

Side Effects of Lacarnit 330 Tablet

  • Vomiting
  • Nausea

This is not a complete list of side effects. Consult your doctor if you experience any unusual symptoms.

Safety Advice for Lacarnit 330 Tablet

Alcohol
CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Lacarnit 330 Tablet. Please consult your doctor.

Pregnancy
SAFE IF PRESCRIBED

Lacarnit 330 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast Feeding
SAFE IF PRESCRIBED

Lacarnit 330 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving
SAFE

Lacarnit 330 Tablet does not usually affect your ability to drive.

Kidney
CAUTION

Lacarnit 330 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lacarnit 330 Tablet may be needed. Please consult your doctor.

Liver
SAFE IF PRESCRIBED

Lacarnit 330 Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lacarnit 330 Tablet may not be needed in these patients. Please consult your doctor.

Frequently Asked Questions

Lacarnit 330 Tablet is not a steroid. It contains Levo-carnitine which is a type of amino acid (made from the amino acids lysine and methionine). It helps in transporting fats to the cells, where fats get metabolized in order to produce energy. It is used to treat primary and secondary Levo-carnitine deficiency.

Carnitine deficiency may be of two types, primary and secondary. Primary is genetic and may show symptoms by five years of age. Whereas, secondary may occur due to certain disorders like kidney problems (chronic kidney failure) and use of antibiotics that reduces its absorption and increases its excretion.

In some patients, warfarin when taken along with Lacarnit 330 Tablet may increase the time required for the formation of blood clot. Hence, before starting Lacarnit 330 Tablet, inform your doctor if you are taking warfarin.

Lacarnit 330 Tablet should be taken as directed by your doctor. Generally, it is advised to be taken 3-4 times daily, preferably with meals or after meals.

Yes, Lacarnit 330 Tablet can be taken by patients with diabetes. However, it is important to know that it contains sucrose. Some studies have shown that it may improve insulin sensitivity. Along with that, it may also be helpful in relieving nerve pain.

Lacarnit 330 Tablet may very rarely cause diarrhea. This effect of the medicine can be reduced by decreasing the dose of Lacarnit 330 Tablet. But, if you are taking oral solution then take it slowly or dilute it more.

Need help with this medicine?

Our licensed pharmacists can help with availability, prescription verification, and ordering support.

Related & alternative brands

Other medicines with a similar composition or name available on Vyloo. Always confirm therapeutic equivalence with your doctor or pharmacist before switching brands.

Lacarnit InjectionRx

Lacarnit Injection

La Renon Healthcare Pvt Ltd · 5.0 ml in 1 ampoule

₹200
Lcarpro 500mg TabletRx

Lcarpro 500mg Tablet

Salud Care India Pvt Ltd · 10.0 tablets in 1 strip

₹255
Evoma-LC TabletRx

Evoma-LC Tablet

Thelma Lifesciences · 10.0 tablets in 1 strip

₹52
Cynocal-LC TabletRx

Cynocal-LC Tablet

Ozone Pharmaceuticals Ltd · 10.0 tablets in 1 strip

₹186
Evion LC TabletRx

Evion LC Tablet

Merck Ltd · 10.0 tablets in 1 strip

₹71
Kebal-LC TabletRx

Kebal-LC Tablet

Chemo Healthcare Pvt Ltd · 10.0 tablets in 1 strip

₹149
Orsivit LC TabletRx

Orsivit LC Tablet

Orsim Pharma · 10.0 tablets in 1 strip

₹42
Benfotor-LC TabletRx

Benfotor-LC Tablet

Cnscure India Pvt Ltd · 10.0 tablets in 1 strip

₹188

Medical information standards

Educational product information for Lacarnit 330 Tablet. Not a substitute for advice from your treating doctor or healthcare provider.

Reviewed by
Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
Content dates
Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
Business address
Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, India
GSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.

Authoritative references